The $21.6 million grant will fund the development of a tuberculosis assay, which will be designed for use in both resource-constrained and well-resourced settings. It will also support the company’s ...

Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc.

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, a potential breakthrough that could allow easier, community-based ...

A simple blood test that accurately diagnoses active tuberculosis could save hundreds of thousands of lives each year, experts said today. The test makes it easier and cheaper to control the disease, ...

Gorakhpur: Students of MSc Nursing (1st year) and BSc Nursing (5th semester) from faculty of nursing and paramedical, Mahayogi Gorakhnath University, organised an awareness programme, ...

WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR) announced today that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill & ...